Novo Nordisk Operating Income 2012-2026 | NVO

Novo Nordisk operating income for the twelve months ending March 31, 2026 was $23.190B, a 19.26% increase year-over-year.

  • Novo Nordisk annual operating income for 2025 was $19.327B, a 3.86% increase from 2024.
  • Novo Nordisk annual operating income for 2024 was $18.609B, a 24.95% increase from 2023.
  • Novo Nordisk annual operating income for 2023 was $14.894B, a 40.6% increase from 2022.

Novo Nordisk Operating Income 2012-2026 | NVO

  • Novo Nordisk annual operating income for 2025 was $19.327B, a 3.86% increase from 2024.
  • Novo Nordisk annual operating income for 2024 was $18.609B, a 24.95% increase from 2023.
  • Novo Nordisk annual operating income for 2023 was $14.894B, a 40.6% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B